Latay

Latanoprost, the active ingredient in Latay, is a prostaglandin analog presented as an ophthalmic solution for ocular (topical) use. It lowers intraocular pressure and is indicated for the management of open‑angle glaucoma and ocular hypertension in adult patients.

GNH USA supplies Latay as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability and regulatory compliance across multiple markets.

Latanoprost is a prostaglandin analog used to lower intraocular pressure in glaucoma‑related conditions.

Open‑angle glaucoma: reduces intraocular pressure to help prevent optic nerve damage and visual field loss. Ocular hypertension: lowers intraocular pressure to decrease the risk of developing glaucoma. Elevated intraocular pressure: provides sustained pressure reduction to maintain ocular health.

Latanoprost may cause ocular and peri‑ocular adverse reactions, most of which are mild and transient.

Common Side Effects: - Eye redness (hyperemia) - Eye irritation or burning sensation - Increased eyelash growth (hypertrichosis) - Darkening of the iris (peri‑ocular pigmentation) - Blurred vision - Foreign body sensation

Serious or Rare Side Effects: - Uveitis or severe eye inflammation - Macular edema leading to visual impairment - Allergic contact dermatitis of the eyelids - Irregular pupil (anisocoria) with photophobia - Persistent ocular pain

Before initiating latanoprost therapy, clinicians should consider several safety and handling precautions.

- Monitor intraocular pressure: assess baseline and periodic measurements to evaluate response. - Assess for ocular infection: avoid use in active conjunctivitis or keratitis. - Use caution in patients with active ocular inflammation: prostaglandin analogs may exacerbate inflammation. - Avoid concurrent use with other prostaglandin analog eye drops: risk of additive side effects. - Evaluate hypersensitivity: discontinue if allergic reaction occurs. - Store at room temperature: keep bottle tightly closed, protect from light and moisture.

Latanoprost can interact with other ophthalmic or systemic agents, influencing efficacy or safety.

Major Interactions (Avoid): - Concomitant use with other prostaglandin analogs: may cause excessive intraocular pressure reduction and heightened ocular irritation. - Use with ocular anesthetic drops containing preservatives: increased risk of corneal toxicity.

Moderate Interactions (Monitor Closely): - Co‑administration with beta‑blocker eye drops: additive IOP‑lowering effect may lead to hypotony. - Use with carbonic anhydrase inhibitor eye drops: potential for over‑reduction of intraocular pressure. - Systemic non‑steroidal anti‑inflammatory drugs: may diminish prostaglandin‑mediated outflow enhancement. - Topical corticosteroids: may counteract latanoprost’s pressure‑lowering effect.